MMJ Group Holdings Ltd

MMJ PhytoTech Limited (ASX:MMJ) is pleased to advise that its wholly-owned subsidiary United Greeneries has executed a binding letter of intent with Cowichan Tribes in respect to the leasing of a 13-acre strategic land package located immediately adjacent to the Company's existing Duncan Facility.

MMJ PhytoTech Ltd (ASX:MMJ) are pleased to provide the Company's latest Investor Presentation for July 2016, 'From Farm to Pharma'.

MMJ PhytoTech Limited (ASX:MMJ) is pleased to provide its shareholders with the below Company update, in the form of a Q&A session with Managing Director Andreas Gedeon.

MMJ PhytoTech Limited (ASX:MMJ) is pleased to advise that, on 30 June 2016, the Canadian federal regulatory authority Health Canada announced the creation of a Task Force on Marijuana Legalization and Regulation.

MMJ PhytoTech Limited (ASX:MMJ) is pleased to advise that it has further strengthened its senior management personnel with the appointment of Richard Jarvis as Chief Financial Officer.

MMJ PhytoTech Limited (ASX:MMJ) is pleased to advise that its wholly-owned Canadian subsidiary United Greeneries has been approved by Health Canada as an authorized Licensed Producer at its flagship Duncan Facility under the Marijuana for Medical Purposes Regulations.

MMJ PhytoTech Limited (ASX:MMJ) is pleased to advise that it has strengthened its senior management and advisory personnel with the appointment of Stanislav Sologubov as Chief Executive Officer of Satipharm Switzerland and John Hollister as a strategic pharmaceutical consultant.

MMJ PhytoTech Limited (ASX:MMJ) is pleased to announce its wholly-owned subsidiary United Greeneries ("UG") has received notification from Health Canada ("HC") that an MMPR Pre-License Inspection of UG's Duncan Facility will be conducted on February 1, 2016.

MMJ PhytoTech Ltd (ASX:MMJ) are pleased to provide an Investor Presentation titled, 'Farm to Pharma: Maximizing Value Along the Chain'.

MMJ PhytoTech Limited (ASX:MMJ) (the "Company") Management and Board are pleased to announce it has received its first wholesale order for its 10mg and 100mg Satipharm CBD Gelpell(R) Gastro-resistant Microgel Capsules ("CBD Capsules" or "Capsules").